Mansoor Amiji
University Distinguished Professor, Pharmaceutical Sciences
University Distinguished Professor, Chemical Engineering
Affiliated Faculty, Bioengineering
Contact
- m.amiji@northeastern.edu
- 360 Huntington Avenue
Boston, MA 02115
Office
- 140 The Fenway, Room 165
- 617.373.3137
Research Focus
Polymeric biomaterials, drug delivery systems, nanomedical technologies
Education
- BS, Pharmacy (magna cum laude), Northeastern University
- PhD, Pharmaceutics, Purdue University
Honors & Awards
- T. Nagai Award, Controlled Release Society
- Fellow, America Association of Pharmaceutical Scientists (AAPS)
- Fellow, Controlled Release Society
- Charivate Analytics Highly Cited Author (top 1%)
- Distinguished Alumni Award, Purdue University College of Pharmacy
Professional Affiliations
- American Association of Pharmaceutical Scientists, Fellow
- Controlled Release Society, Fellow
Research Overview
Polymeric biomaterials, drug delivery systems, nanomedical technologies
Selected Research Projects
- Development and Validation of a Novel Cas13a and Nanoparticle Guide-RNA Delivery System that Allows Precise Ablation of Host Macrophage Populations in a Humanized Mouse Model
- – Principal Investigator, Jackson Laboratories on a National Institutes of Health
- Direct CNS Delivery System for BDNF AntagoNATs using Heterotopic Mucosal Grafting for the Treatment of Parkinson’s Disease
- – Principal Investigator, National Institutes of Health
Department Research Areas
Selected Publications
- J. Bae, N. Parayath, W. Ma, M. Amiji, N. Munshi, K. Anderson, Bcma Peptide Engineered Nanoparticles Enhance Induction and Function of Antigen Specific Cd8+ Cytotoxic T Lymphocytes Against Multiple Myeloma, Nature – Leukemia, 34, 2020, 210–223
- N.N. Parayath, S. Padmakumar, M. Amiji, Extracellular Vesicle-Mediated Nucleic Acid Transfer and Reprogramming in the Tumor Microenvironment, Cancer Letters, 482(10), 2020, 33-43
- G. Ahmad, G. Mackenzie, J. Egan, M. Amiji, Dha-Sbt-1214 Taxoid Nanoemulsion and Anti-Pd-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model, Molecular Cancer Therapeutics, 18(11), 2019, 961-1972
- D. Chen, N. Parayath, S. Ganesh, W. Wang, M. Amiji, Role of Apolipoprotein-and Vitronectin-Enriched Protein Corona on Lipid Nanoparticles for in Vivo Targeted Delivery and Transfection of Oligonucleotides in Murine Tumor Models, Nanoscale, 11, 2019, 18806–18824
Dec 27, 2022
Everything to know about the common cold and how to treat symptoms
“Our study is really focused on prevention, that initial exposure and how to enhance your defenses,” said lead author Mansoor Amiji, professor of pharmaceutical sciences at Northeastern University. (Featured in USA Today)
Nov 02, 2022
2022 Stanford University Annual Assessment of Author Citations
The following COE professors are among the top scientists worldwide selected by Stanford University representing the top 2 percent of the most-cited scientists with single-year impact in various disciplines. The selection is based on the top 100,000 by c-score (with and without self-citations) or a percentile rank of 2% or above. The list below includes […]
Sep 20, 2022
Fall 2022 Spark Fund Awardees
Bouve/ChE University Distinguished Professor Mansoor Amiji, ChE Assistant Professor Sara Hashmi, ECE Professor Purnima Ratilal-Makris, and MIE Assistant Professor Mohsen Moghaddam are recipients of the Fall 2022 Spark Fund Awards. The goal of the award is to advance a technology or suite of technologies from academia towards commercialization.
Aug 26, 2022
Moderna sues Pfizer and BioNTech over COVID vaccine patents
“We’re seeing a lot of lawsuits related to mRNA vaccines right now, so I wasn’t surprised about this particular lawsuit,” said Mansoor Amiji, a professor of pharmaceutical sciences and chemical engineering at Northeastern University. (Featured in The Boston Globe)
Jul 06, 2022
Announcing the new MS in Pharmaceutical Engineering at Northeastern University
The College of Engineering and Bouve College of Health Sciences at Northeastern University are offering a new Master of Science in Pharmaceutical Engineering. Both colleges began to recognize the growing need in the pharmaceutical sector for people that have both an engineering background as well as understand the regulatory environment of the pharmaceutical industry. “The […]
Dec 23, 2021
COE Professors Selected in Stanford University List of Top 2% Scientists Worldwide
The following COE professors are among the top scientists worldwide selected by Stanford University representing the top 2 percent of the most-cited scientists with single-year impact in various disciplines. The selection is based on the top 100,000 by c-score (with and without self-citations) or a percentile rank of 2% or above. The list below includes […]
Apr 20, 2021
FY22 TIER 1 Award Recipients
Congratulations to the 17 COE faculty and affiliates who were recipients of FY22 TIER 1 Interdisciplinary Research Seed Grants for 11 different projects.
Feb 12, 2021
Developing Technology to Optimally Detect and Count Circulating Tumor Cells without Drawing Blood
BioE Professor Mark Niedre and Bouve/ChE Professor Mansoor Amiji are using their recent NCI/NIH grant to detect circulating tumor cells in the blood.
Jan 07, 2021
Niedre and Amiji Receive National Cancer Institute Award
Bioengineering Professor and Associate Chair Mark Niedre and Bouve/ChE Distinguished Professor Mansoor Amiji received a 2-year, $400K grant titled “Fluorescence Molecular In Vivo Liquid Biopsy of Circulating Tumor Cells” from the National Cancer Institute and National Institutes of Health.
Nov 12, 2020
Will the Vaccine Be Effective?
Bouve/ChE University Distinguished Professor Mansoor Amiji explains how Pfizer’s new vaccine for COVID will work. This vaccine could prevent COVID-19 in 9 out of 10 people. But how does it work? On Monday, the pharmaceutical company Pfizer announced that its COVID-19 vaccine is more than 90 percent effective at preventing the disease according to preliminary […]